To be technically accurate, sudden cardiac death in young athletes is rare but devastating. Population ECG screening reduces some events but causes false positives, costs, and anxiety. Priorities: AEDs at venues, trained responders, clear emergency plans, and targeted cardiology referral for concerning history — not one-size-fits-all screening.
To be technically accurate, PMS actionability comes from a documented process and clear triggers; MDR Art. 83/84 drive the PSUR cadence.
To be technically accurate, MDR-aligned documentation should remain living and traceable.
To be technically accurate, data feeds must be timely and actionable for PM surveillance.
To be technically accurate, understaffed Notified Bodies and underfunded competent authorities are a public‑health risk — delayed CE marks mean delayed patient access. Policy should fund NB capacity, issue clear transitional guidance, and prioritise high‑risk devices; industry must stop treating confomrity as a one‑time checkbox.
To be technically accurate, public health policy that ignores the regulatory workload of medical devices invites supply squeezes. Clarity and funded capacity for Notified Bodies and authorities are public‑health measures, not bureaucratic luxuries. Industry must improve — but regulators must enable.
To be technically accurate, cross-functional data feeds are essential for effective post-market surveillance.
To be technically accurate, risk communications must be evidence-based and MDR-aligned.
to be technically accurate, practical regulatory work keeps us compliant—documentation is king.
To be technically accurate, a normal ECG is a snapshot — useful but not definitive. It can miss paroxysmal arrhythmias, transient ischaemia, early structural disease or metabolic/electrolyte issues; clinical exam, serial ECGs, ambulatory monitoring, biomarkers or imaging are often needed.